Metastatic Breast Cancer| IBRANCE® (palbociclib) Capsules| Safety Info

Finding your new normal

As a woman diagnosed with metastatic breast cancer (MBC), a lot may have changed – but a lot hasn’t.

IBRANCE^® is the #1 prescribed, FDA-approved oral combination treatment for women with HR+, HER2- MBC.

IBRANCE^® is the #1
prescribed, FDA-approved
oral combination treatment
for women with HR+, HER2-
metastatic breast cancer.

INDICATIONS: IBRANCE is a prescription medicine used to treat HR+, HER2- breast cancer that has spread to other parts of the body (metastatic) in combination with an aromatase inhibitor as the first hormonal based therapy in women who have gone through menopause, or fulvestrant in women with disease progression following hormonal therapy.

Is Here For You

FINANCIAL ASSISTANCE If you can’t afford your medicine, we’re here to help by assisting with co-pays* or providing IBRANCE for free to eligible patients.

SUPPORT BEYOND TREATMENT At Pfizer Oncology Together, we’re here to help. One of our Care Champions will help you get the support you need—all in one place.

Alternate Image

Limits, terms, and conditions apply. Patients may receive up to $25,000 in savings annually. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. For more information, please call 1-844-9-IBRANCE, visit PfizerOncologyTogether.com, or write: Pfizer Oncology Together Co-Pay Savings Program, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560.

Get To Know Women Taking IBRANCE

See Their Stories

Support, Resources, And Insights To Help You Learn More About IBRANCE

IBRANCE Answers delivers facts and resources to help you understand more about IBRANCE and find helpful support throughout treatment.

Sign Up for
IBRANCE Answers

IMPORTANT SAFETY INFORMATION AND INDICATIONS

Terms and Conditions

By enrolling in this co-pay offer, you acknowledge that you currently meet the eligibility criteria and will comply with the Terms and Conditions described below:

This card is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, Tricare or other federal or state healthcare programs (including any state prescription drug assistance programs) and the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).
This card is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other health or pharmacy benefit programs.
With this card you will pay a $0 co-pay per eligible monthly prescription, subject to a maximum benefit of $25,000 per calendar year. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $25,000 you will be responsible for the remaining monthly out-of-pocket costs. This card may be used once per 30 days until the maximum benefit has been reached. The average benefit is $437.55 per patient per year.
You must deduct the value of the benefit you receive with this card from any reimbursement request submitted to your insurance plan, either directly by you or on your behalf.
This card is not valid where prohibited by law.
Card cannot be combined with any other rebate/coupon, free trial or similar offer for the specified prescription.
Card will be accepted only at participating pharmacies.
This card is not health insurance.
Offer good only in the U.S. and Puerto Rico.
Card is limited to 1 per person during this offering period and is not transferable.
Pfizer reserves the right to rescind, revoke or amend this offer without notice.
No membership fee.
Offer expires 12/31/2019.
For reimbursement when using a nonparticipating pharmacy: Mail a copy of the patient’s pharmacy receipt indicating patient name, name of medication purchased, price paid, and date purchased, along with a copy of the patient’s Pfizer Oncology Together Co-Pay Savings Card, to:

Pfizer Oncology Together Co-Pay Savings Program

2250 Perimeter Park Drive, Suite 300

Morrisville, NC 27560

Important Safety Information and Indications

isi-top-contentIBRANCE may cause serious side effects, including:

Low white blood cell counts (neutropenia). Low white blood cell counts are very common when taking IBRANCE and may cause serious infections that can lead to death. Your doctor should check your white blood cell counts before and during treatment.

If you develop low white blood cell counts during treatment with IBRANCE, your doctor may stop your treatment, decrease your dose, or may tell you to wait to begin your treatment cycle. Tell your doctor right away if you have signs and symptoms of low white blood cell counts or infections such as fever and chills.

isi-before-you-take-ibranceBefore you take IBRANCE, tell your doctor if you:

have fever, chills, or any other signs or symptoms of infection.
have liver or kidney problems.
have any other medical conditions.
are pregnant or plan to become pregnant; IBRANCE can harm your unborn baby.

Females who are able to become pregnant and who take IBRANCE should use effective birth control during treatment and for at least 3 weeks after stopping IBRANCE.
Males who are taking IBRANCE and have female partners who can become pregnant should use effective birth control during treatment with IBRANCE and for 3 months after the final dose of IBRANCE.

are breastfeeding or plan to breastfeed; it is not known if IBRANCE passes into your breast milk. You and your doctor should decide if you will take IBRANCE or breastfeed. You should not do both.

isi-common-side-effectsCommon side effects of IBRANCE include:

Low red blood cell counts and low platelet counts. Call your doctor right away if you develop any of these symptoms during treatment:

dizziness
shortness of breath
weakness

bleeding or bruising more easily
nosebleeds

infections
tiredness
nausea
sore mouth
abnormalities in liver blood tests

diarrhea
hair thinning or hair loss
vomiting
rash
loss of appetite

IBRANCE may cause fertility problems in males. This may affect your ability to father a child. Talk to your doctor if this is a concern for you.

These are not all of the possible side effects of IBRANCE. For more information, ask your doctor. Tell your doctor if you have any side effect that bothers you or does not go away.

Tell your doctor about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. IBRANCE and other medicines may affect each other, causing side effects.

Do not drink grapefruit juice or eat grapefruit products while taking IBRANCE as they may increase the amount of IBRANCE in your blood.

Tell your doctor if you start a new medicine. Take IBRANCE exactly as your doctor tells you.

isi-take-ibrance-hcp-tells-you

If you take too much IBRANCE, call your doctor right away or go to the nearest hospital emergency room.

isi-anchor-indications

INDICATIONS

IBRANCE is a prescription medicine used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has spread to other parts of the body (metastatic) in combination with:

an aromatase inhibitor as the first hormonal based therapy in women who have gone through menopause, or
fulvestrant in women with disease progression following hormonal therapy.

Please see Full Prescribing Information and Patient Information.

Enable JavaScript to visit this website.